Fundz

Pheast Therapeutics

PALO ALTO, CA · Biotechnology · 39 employees

Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.

Funding history

  • Venture - Series Unknown — $24.6M — Oct 2025
  • Venture - Series Unknown — $75.3M — Apr 2025
  • Venture - Series Unknown — $75.3M — Oct 2022

Recent signals

  • Oct 16, 2025: Raised $24.6M in Venture - Series Unknown
  • Apr 10, 2025: Raised $75.3M in Venture - Series Unknown
  • Oct 28, 2022: Raised $75.3M in Venture - Series Unknown

See plans & pricing → Track Pheast Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.